Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97% Market Closed
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Panacea Biotec Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Panacea Biotec Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Panacea Biotec Ltd
NSE:PANACEABIO
Net Income (Common)
-â‚ą148.6m
CAGR 3-Years
58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Net Income (Common)
-â‚ą184.8m
CAGR 3-Years
-79%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Net Income (Common)
-â‚ą2.6m
CAGR 3-Years
71%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Net Income (Common)
â‚ą66.6m
CAGR 3-Years
14%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Hester Biosciences Ltd
NSE:HESTERBIO
Net Income (Common)
â‚ą234.7m
CAGR 3-Years
-20%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Net Income (Common)
â‚ą14.4B
CAGR 3-Years
31%
CAGR 5-Years
11%
CAGR 10-Years
13%
No Stocks Found

Panacea Biotec Ltd
Glance View

Market Cap
26.5B INR
Industry
Biotechnology

Panacea Biotec Ltd. is a biotechnology company, which is engaged in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. The company is headquartered in New Delhi, Delhi. The Company’s research areas include new chemical entities (NCE), new biological entities (NBE) novel drug delivery system (NDDS) based pharmaceutical formulations, novel peptides and human monoclonal antibodies and vaccine development. The Company’s product portfolio includes pain management, diabetes & cardiovascular management, oncology, renal disease management, osteoporosis management, anti-tubercular, gastrointestinal care products and vaccines. The Company’s subsidiaries include Panacea Biotec Pharma Limited, Panacea Biotec (International) SA, PanEra Biotec Private Limited and Meyten Realtech Private Limited.

PANACEABIO Intrinsic Value
178.94 INR
Overvaluation 59%
Intrinsic Value
Price

See Also

What is Panacea Biotec Ltd's Net Income (Common)?
Net Income (Common)
-148.6m INR

Based on the financial report for Sep 30, 2024, Panacea Biotec Ltd's Net Income (Common) amounts to -148.6m INR.

What is Panacea Biotec Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
58%

The average annual Net Income (Common) growth rates for Panacea Biotec Ltd have been 58% over the past three years .

Back to Top